Georgia Departmental Registry 2026: Legal Effect of Medical Device Registration Records

1. Key takeaways

The final legal effect of medical device registration in Georgia is entry in the departmental registry, based on Article 11⁶ of the Law of Georgia on Medicines and Pharmaceutical Activities, Law No. 1586 (10 August 2009). The registry is maintained by the Regulation Agency for Medical and Pharmaceutical Activities, and its format and maintenance procedures are approved by the ministry under Article 3(2)(c). For three categories of business scenarios, namely tenders, customs clearance and channel access, the burden of proof ultimately points to the registry record rather than to the paper certificate. This inverted hierarchy surprises many manufacturers who treat the certificate as the terminal deliverable of the project. In Georgia, the certificate is the internal evidence of an authorisation, while the registry record is the publicly verifiable object that third parties rely on. Any mismatch between the two, in name, model, manufacturer or validity period, converts a routine tender or clearance step into an investigation of its own, so the reconciliation of certificate and registry should be treated as a mandatory closing action of every registration project.

The registry also functions as the connective tissue between registration and the rest of the commercial lifecycle. Tenders require proof of registered status at bid time; customs requires it at each import; distributors and pharmacy chains require it before listing a product. Because all three audiences consult the same record, an error in the registry propagates simultaneously into three commercial channels, and a correction filed promptly for one audience prevents the same defect from surfacing in the other two. The registry query is therefore not an administrative afterthought but a standing commercial control, and the query evidence, with its date, belongs in the same archive as the certificates themselves. Companies that assign this reconciliation to a named owner, with a monthly cadence, report that discrepancies are caught while they are still trivial to correct.

2. Legal basis

1. Law of Georgia on Medicines and Pharmaceutical Activities, Law No. 1586, adopted on 10 August 2009: Article 1¹ definition of departmental registry.
2. Article 3(2)(c): the state approves the format and the maintenance procedures of the departmental registry.
3. Article 3(3)(c): the agency maintains the departmental registry.
4. Article 11⁶ (Article 116), paragraph 4: under the recognition regime, products may be entered in the departmental registry proactively or after administrative review.
5. Article 11⁶, paragraph 5: entry in the departmental registry after completion of the procedure under Article 11¹¹ under the national regime.
6. Article 11¹⁰ (Article 1110), paragraph 6: the agency may revoke the registration and remove the product from the departmental registry.

3. Expert insights

Insight 1: the registry is the result, not a stage. Article 11⁶ paragraphs 4 and 5 regulate the conditions of entry under the recognition regime and the national regime respectively, which shows that entry is the concluding action after a successful review. What the company receives is a registration document, but what produces public legal effect towards third parties is the registry record. Where the two are inconsistent, the registry prevails. This hierarchy has practical consequences for evidence design: screenshots and registry extracts should be generated close to the moment of use, dated, and archived with the tender or clearance file, because a stale extract can be as damaging as a mismatch when a procurement officer or customs officer compares it against the current registry state.

Insight 2: Article 11⁶ paragraph 4 leaves room for proactive entry under the recognition regime. The wording is that products may be entered proactively or after administrative review, which means that under the recognition regime entry without full administrative review is possible. This is the institutional root of the significantly shorter timeline of the recognition regime compared with the national regime, and it is the channel that companies should prioritise. The word may also signals discretion: proactive entry is an option the authority exercises where the file is complete and the sameness evidence is clean, so the quality of the submission directly determines whether the fast lane is actually used. To maximise the chance of proactive entry, companies should pre-clear the three elements the reviewing officer will check first: the authenticity and completeness of the sameness document, the exact correspondence of product names and models between the reference approval and the local application, and the validity period of the reference authorisation at the date of entry. A single mismatch in any of these elements converts the file from a proactive entry candidate into an administrative review case. Pre-clearance is cheap: it consists of a self-audit against the same checklist the authority applies, performed before submission, and its cost is a fraction of the timeline saved when the fast lane is granted.

Insight 3: revocation and removal are two sides of one action. Article 11¹⁰ paragraph 6 provides that when the agency revokes a registration, it removes the product from the departmental registry. The consequence of a post-market violation is therefore not only a fine, but the loss of registered status, which directly affects the legality of products already on sale. In post-market compliance planning, the bottom-line objective of the company should be to preserve the registry record. Every post-market decision, from a delayed variation to a missed reporting duty, should be evaluated against that bottom line, because the cost of losing the record is measured across the whole portfolio, not in a single administrative penalty.

4. Practical recommendations

1. After certification, immediately reconcile the registry record with the certificate information, covering name, model, manufacturer and validity period, and request correction without delay if a deviation is found.
2. In tender and channel access packages, include both the certificate scan and a registry query screenshot, annotated with the query date.
3. Establish a monthly self-check of registered status to prevent revocation caused by missed annual reports or variation filings.
4. On a change of legal entity, update the registry information in parallel under Article 11⁶ and do not stop at updating the commercial register.

5. Verification checklist

• □ Reconciled the registry record with the certificate information
• □ Archived registry query screenshots together with the query dates
• □ Established the monthly self-check mechanism for registered status
• □ Updated the registry in parallel on the change of legal entity
• □ Obtained and archived the authentic text of Article 11⁶

GRZAN international services — GRZAN supports registered status management in Georgia, including registry reconciliation, tender evidence packages and post-market compliance monitoring. For enquiries about this guide, contact info@grzanglobal.com.

Regulatory information verified as of October 30, 2026